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Abstract: Biofabrication and maturation of bone constructs is a long-term task that requires a
high degree of specialization. This specialization falls onto the hierarchy complexity of the bone
tissue that limits the transfer of this technology to the clinic. This work studied the effects of the
short-term cryopreservation on biofabricated osteoblast-containing structures, with the final aim to
make them steadily available in biobanks. The biological responses studied include the osteoblast
post-thawing metabolic activity and the recovery of the osteoblastic function of 3D-bioprinted
osteoblastic structures and beta tricalcium phosphate (β-TCP) scaffolds infiltrated with osteoblasts
encapsulated in a hydrogel. The obtained structures were cryopreserved at −80 ◦C for 7 days using
dimethyl sulfoxide (DMSO) as cryoprotectant additive. After thawing the structures were cultured
up to 14 days. The results revealed fundamental biological aspects for the successful cryopreservation
of osteoblast constructs. In summary, immature osteoblasts take longer to recover than mature
osteoblasts. The pre-cryopreservation culture period had an important effect on the metabolic activity
and function maintain, faster recovering normal values when cryopreserved after longer-term culture
(7 days). The use of β-TCP scaffolds further improved the osteoblast survival after cryopreservation,
resulting in similar levels of alkaline phosphatase activity in comparison with the non-preserved
structures. These results contribute to the understanding of the biology of cryopreserved osteoblast
constructs, approaching biofabrication to the clinical practice.
Keywords: biofabrication; bioprinting; cryopreservation; bone construct; osteoblast; metabolic
activity; ALP activity
1. Introduction
In 2016, Groll et al. described biofabrication in the context of tissue engineering and regenerative
medicine as the application of automatic manufacturing processes to generate cell-biomaterial
constructs that through the spatial arrangement of their components may mature into functional tissue
equivalents [1]. This description is closely related to the aim of tissue engineering to develop biological
substitutes that restore, maintain or improve the structure and function of damaged tissues or organs [2].
Biofabricated cell-material constructs aim to mimic tissue specific hierarchical features, consequently,
their use is not limited to regenerative medicine applications, but they are also used as complex
three-dimensional (3D) in vitro models for the study of developmental biology [3,4], cell biology [5,6],
personalized pharmacokinetics [7] and disease pathogenesis [8,9]. In practice, biofabrication involves
the structural aggregation of cells, materials, extracellular matrix components, bioactive molecules and
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possibly pre-biofabricated building blocks to control the fate of the stem cells [10,11]. Biofabrication
should benefit from the computer-aided design, but it can use the original tissue engineering approach,
where cells are seeded and cultured onto the scaffold, which in turn was produced either by additive
manufacturing or by traditional casting or subtractive manufacturing approaches.
Despite bone tissue has a significant reparative capacity, more than two million grafts are
performed annually to treat bone defects caused by degenerative diseases, accidents, tumours,
infections and congenital diseases [12,13]. Therefore, bone regenerative medicine is one of the fields
where biofabrication could provide an alternative that satisfies the increasing demand for bone grafts.
However, the biofabrication of functional bone substitutes is a long task that requires specialization due
to the hierarchical complexity of the bone tissue, restricting the transfer of this technology towards the
clinic and hinders its routinely use to study fundamental aspects of bone biology. The cryopreservation
of biofabricated bone substitutes is an interesting alternative to promote their transfer towards clinical
and experimental practices. By cryopreservation, it will be possible to store ready-to-use bone
substitutes in biobanks and their on-demand transportation, escaping in situ manufacturing and
long maturation processes. The lasts could be performed in specialized laboratories following good
manufacturing practices, therefore, fulfilling international standards.
Cryopreservation is the use of very low temperature to preserve living cells and tissues in a
quiescent status for a long period, without losing their viability, activity, and function [14]. Several works
have been devoted to the cryopreservation of engineered biological substitutes [15–25], but there is still
the need for information on the cryopreservation of biofabricated osteoblast constructs, a paramount
goal addressed in this work. Pioneer studies demonstrate that post-thawing osteoblast viability
was better maintained (40–50%) when cryopreserved in dimethyl sulfoxide (DMSO) than in other
cryoprotectant additives [26,27]. Moreover, it was reported that post-thawing cell viability was
reduced for attached osteoblasts and increased with osteoblast density [27]. Unlike those early studies
concentrated in the osteoblast post-thawing viability due to the use of different cryoprotectant
additives under traditional two-dimensional (2D) cell culture, this work aims to evaluate the
recovery of the metabolic activity and function of 3D-bioprinted osteoblast-containing structures
and hydrogel-encapsulated osteoblasts infiltrated in beta-tricalcium phosphate (β-TCP) scaffolds;
both freshly biofabricated structures were named osteoblast constructs for the sake of simplicity.
Among the different alternatives, a hydrogel mixture composed of gelatine with alginate was selected
for the encapsulation and 3D-bioprinting of osteoblasts. This hybrid hydrogel is easily processed into
3D structures, shows short-term stability after ionic crosslinking, supports cell proliferation in vitro,
promotes better cell metabolic activity than pure alginate and supports bone healing in vivo [28–32].
Besides, the rationale of the use of β-TCP scaffolds was to mimic the chemical and mechanical
microenvironment in bone tissue and, therefore, increase the structural properties of the constructs for
better long-term in vitro manipulation. Variables such as the osteoblast maturity phenotype and the
pre-cryopreservation culture period were studied for the first time and compared with the results of
non-preserved counterparts. The short-term cryopreservation at −80 ◦C was studied as the proof of
concept, discovering important aspects for the successful cryopreservation of osteoblast constructs.
2. Materials and Methods
2.1. Cell Culture
The study was performed using two different human osteoblastic cell lines, MG-63 (ATCC®
CRL-1427™, Manassas, VA, USA) and Saos-2 (ATCC® HTB-85™, Manassas, VA, USA), maintained
in Dulbecco’s Modified Eagle Medium (DMEM, Corning, NY, USA) supplemented with 10% Foetal
Bovine Serum (FBS, Corning NY, USA) and antibiotics (streptomycin 100 µg/mL, penicillin 100 UI/mL
and fungizone 0.3 µg/mL, Sigma-Aldrich, St. Louis, MS, USA). Despite the two cell lines having an
osteosarcoma origin they are commonly used as an osteoblastic in vitro model in experiments that
require large numbers of cells, generating reproducible results [33,34]. For all the experiments the
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cell lines were used at 3–6 passages after standard cryopreservation in liquid nitrogen, using DMSO
(Sigma-Aldrich, St. Louis, MS, USA) as cryoprotectant, and 2 independent biological replicates with
3 samples per test were used for statistical analysis. The cultures were incubated at 37 ◦C in a 100%
humidified atmosphere with 5% CO2 and medium renewal every 3 days.
2.2. Bioprinting and Culture of Osteoblast Constructs
The ink for cell printing was optimized following the methods described previously [28–30,35]
and consisted of 10 wt.% sterile gelatine (Bovine skin type-B, Bloom number of 225 g, Sigma-Aldrich,
St. Louis, MS, USA) and 2 wt.% sterile sodium alginate (120,000–190,000 g/mol and M/G ratio of 1.56,
Sigma-Aldrich, St. Louis, MS, USA) dissolved in FBS. The ink was mixed under sterile conditions
in a dual asymmetric centrifugal mixer (DAC 150, Speedmixer, Hamm, Germany) at 3500 rpm for
5 min at 60 ◦C. Despite the short mixing time, the temperature used may have led to the partial
heat-inactivation of FBS. However, it was not considered a disadvantage because several cell culture
studies are performed with heat-inactivated FBS and the fact that the cell culture medium contains
fresh FBS. Afterwards, MG-63 or Saos-2 cells at 95% of confluence were detached from the cell culture
flask using Trypsin-EDTA solution (Sigma-Aldrich, St. Louis, MS, USA) and the cells were centrifuged
and suspended in the ink at 37 ◦C at a density of 1 × 106 cells/mL. Then, 3 mL of the bioink (ink
containing osteoblast) was transferred into the cartridge of the robotic dispensing device (Pastecaster,
Fundació CIM, Barcelona, Spain) and the osteoblast constructs were fabricated by extrusion under
sterile conditions, i.e., placing the device inside a laminar flow cabinet and sterilising all the materials
in direct contact with the cells by autoclave prior to bioprinting. The Pastecaster robot is not equipped
with a heating system, therefore, the fabrication was started when the flow of the bioink at the outlet
of the dispensing nozzle (250 µm SmoothFlow tapered tip, Nordson EFD, East providence, RI, USA)
was visually suitable for printing, i.e., the bioink filament was continuous and does not flow when
deposited on the printing platform. Presumably, this condition was achieved when the temperature of
the bioink in the cartridge was 25 ◦C [35] and was maintained long enough to extrude all the bioink.
The room temperature in the cell culture lab was 22 ◦C.
A G-code was digitally designed in MATLAB (Version 9.4.0.813654, The MathWorks, Inc.,
Natick, MA, USA) to deposit automatically one construct of 12 mm in diameter by 1 mm in height in
each well of a standard 24-well cell culture plate. The parameters for 3D-bioprinting were set as follows:
cartesian grid pattern with a distance between filaments of 500 µm to allow mass transport, four layers
of 250 µm of height, printing speed of 10 mm/s and pressure of 110 kPa. After fabrication, each construct
was immersed in 50 µL of CaCl2 solution (100 mM, Lach-Ner, Neratovice, Czech Republic) at 10 ◦C
for the ionic cross-linking of alginate, increasing the structural properties of the constructs [30].
Immediately, 500 µL of cell culture medium preheated at 37 ◦C was added and the constructs were
maintained at 37 ◦C for up to 7 days.
Cell viability after bioprinting was determined by a live/dead viability kit (Invitrogen, Waltham,
MA, USA). Briefly, the samples were rinsed in PBS and incubated for 15 min with 2 µM Calcein-AM
and 1.5 µM ethidium homodimer-1 solution in PBS and finally rinsed twice in PBS before imaging with
a fluorescent microscope coupled to a CCD camera (Zeiss, Oberkochen, Germany), using appropriate
filter sets. Cell viability was measured via counting live (green) and dead (red) cells using ImageJ
software (National Institutes of Health, Bethesda, MD, USA). The cell metabolic activity was evaluated
by XTT assay (Section 2.6) and the osteoblastic phenotype was evaluated by the alkaline phosphatase
(ALP) activity (Section 2.7) and Alizarin red S staining (Section 2.8).
2.3. Additive Manufacturing of Beta Tricalcium Phosphate Scaffolds
Commercial β-TCP powder (GPR Rectapur VWR, BDH Prolabo, Leuven, Belgium) with a median
particle size of 2.3 µm and Poloxamer 407 (Sigma-Aldrich, St. Louis, MS, USA) were used to prepare
the ceramic ink for robocasting as described by Casas-Luna et al., [36]. Briefly, 3 g of β-TCP powder
was mixed with 3 g of Poloxamer 407 aqueous solution (40 wt.%) to obtain the ink that was transferred
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into the cartridge (3cc Optimum® Syringe Barrels, Nordson EFD, East providence, RI, USA) of the
robotic deposition device (Pastecaster, Fundació CIM, Barcelona, Spain). Immediately, 5-layer scaffolds
with 11 mm in diameter and 2 mm in height were deposited at 22 ◦C at a printing rate of 8 mm/s,
using cartesian grid pattern and a tapered dispensing nozzle of 410 µm (SmoothFlow Tapered Tips,
Nordson EFD, East providence, RI, USA). The nominal pore size in the printing plane was set to
400 µm. The extrusion force was adjusted to maintain a steady extrusion rate matching the printing
rate. After drying at room temperature the scaffolds were sintered at 1200 ◦C for 5 h. Representative
images of the microstructure of the scaffolds were obtained with a scanning electron microscope (SEM;
TESCAN Lyra3, Brno, Czech Republic), using an electron beam voltage of 5 kV in carbon-coated
samples. Finally, the scaffolds were sterilized by gamma irradiation at 25 KGy prior to perform
cell cultures.
2.4. Cell Culture in Beta Tricalcium Phosphate Scaffolds
Only mature osteoblastic phenotype cells (Saos-2) were used for the evaluation of the 3D-culture
in β-TCP scaffolds. Briefly, Saos-2 cells were suspended at 37 ◦C at a density of 1.5 × 106 cells/mL in a
hydrogel solution composed of 3 wt.% gelatine and 2 wt.% sodium alginate in FBS. In this case, a high
stiffness hydrogel is not required, as the structural stability of the construct will be provided by the
β-TCP scaffold. Consequently, the gelatine concentration was reduced in comparison with the bioink
for cell printing (Section 2.2). One drop of the cell suspension (100 µL) was added to each scaffold for
osteoblasts infiltration and immediately was crosslinked with 50 µL of CaCl2 solution (100 mM) at
10 ◦C. Afterwards, 500 µL of cell culture medium preheated at 37 ◦C was added and the constructs
were maintained at 37 ◦C for up to 21 days. Note that the cell density of the suspension was increased
in order to have similar initial cell density in the construct than in 3D-bioprinting. The cell metabolic
activity was evaluated by XTT assay (Section 2.6) and the osteoblastic phenotype was evaluated by the
ALP activity (Section 2.7).
2.5. Cryopreservation of the Osteoblast Constructs
3D-bioprinted osteoblast constructs and β-TCP scaffolds infiltrated with encapsulated osteoblasts
were subject to the cryopreservation protocol after 3 and 7 days of culture. Such points were selected
to allow the recovery of the cell viability after biofabrication and promote cell–cell interactions within
the constructs. Briefly, after being washed two times with PBS at 37 ◦C, the samples were transferred
to a new 24-well cell culture plate and covered with 500 µL of 20% DMSO (Sigma-Aldrich, St. Louis,
MS, USA) at 4 ◦C diluted in cell culture medium. Immediately the plate containing the samples
was frozen at a cooling rate of 1 ◦C/min up to −50 ◦C (Epsilon 2-10D LSCplus, Christ, Osterode am
Harz, Germany) and finally stored in a freezer at −80 ◦C (ProfiMaster PMU0485, National Lab GmbH,
Moelln, Germany). For the evaluation of the cell metabolic activity (Section 2.6) and the ALP activity
(Section 2.7) after cryopreservation the samples were thawed by adding 500 µL of cell culture medium
at 37 ◦C. Immediately after samples defrosted the medium was removed; the samples were washed
two times with cell culture medium and continued their culture up to 14 days at 37 ◦C in 500 µL of
medium. The biological assays referred were performed immediately after thawing and after 7 and
14 days of effective culture, i.e., without considering the period of cryopreservation. Results were
compared with the outcomes of the counterparts cultured for the same periods but non-cryopreserved.
2.6. Cell Metabolic Activity
Cell metabolic activity was evaluated with and without the cryopreservation of the constructs by
XTT assay (Thermo Fisher Scientific Inc., Waltham, MA, USA). The assay is based on the cleavage of the
tetrazolium salt XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide) in the
presence of an electron-coupling reagent, producing a soluble formazan salt. The concentration of the
formazan product is directly proportional to the number of metabolically active cells. Briefly, constructs
were washed three times with PBS and then transferred to a new cell culture plate to discard the cells that
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could be attached to the bottom of the wells. Afterwards, the constructs were incubated at 37 ◦C for 2 h
with 500 µL of the XTT labelling mixture (0.4 mg/mL) in complete cell culture medium. Then, 150 µL of
the supernatant per sample was transferred to a 96-well cell culture plate and the optical absorbance (OA)
was quantified by spectrophotometry at 450 nm with a plate reader. Results are reported as relative fold
change in comparison with OA measured after 3 days of cell culture without cryopreservation.
2.7. Alkaline Phosphatase Activity
The ALP activity was evaluated with and without cryopreservation of the constructs by an ALP
colorimetric assay kit (Abcam plc, Cambridge, UK). Before the assay, cell culture medium was removed,
the constructs were washed three times with PBS and lysed using 400 µL of 0.1% Triton X-100 in PBS
for 10 min at 37 ◦C. All the lysates were centrifuged at 4 ◦C for 15 min at 15000 rpm to remove solid
particles. To perform the ALP assay, 80 µL of lysate was incubated for 1 h at room temperature in a
96-well plate with 50 µL of 5 mM p-nitrophenyl phosphate (pNPP) solution. Afterward, the reaction
was stopped with 20 µL of stop solution and the OA was quantified by spectrophotometry at 405 nm
with a plate reader. Three replicates per sample were tested. The ALP activity was calculated as the
p-nitrophenol (pNP) generated by samples during the incubation per unit of sample volume per minute
of reaction. The assay is based on the dephosphorylation of pNPP by the ALP enzyme generating
a yellow colour. A standard curve was produced with the ALP enzyme provided in the assay kit,
which reacted with serial dilutions of pNPP.
2.8. Alizarin red S Staining
The recovery of the mature osteoblast function after cryopreservation was determined by visual
detection of cell-mediated deposition of calcium salts using Alizarin red staining. Briefly, 3D-bioprinted
cryopreserved constructs were washed two times with PBS after 7 days of culture, then incubated with
40 mM Alizarin red S solution (Sigma-Aldrich, St. Louis, MS, USA) for 30 min at room temperature,
thoroughly washed with distilled water to remove the excess of Alizarin dye and photographed using
a stereomicroscope (Olympus DSX-HRSU, Tokyo, Japan). 3D-cultures in β-TCP scaffolds were not
stained due to the chemical nature of calcium phosphates that intensely interact with Alizarin red.
2.9. Cell Morphology in Tricalcium Phosphate Scaffolds
The morphology of the cells encapsulated in the hydrogel infiltrated in the β-TCP scaffolds was
examined by confocal microscopy (Axio Observer.Z1 with confocal unit LSM 800, Zeiss, Oberkochen,
Germany). Briefly, the samples were washed three times with PBS, fixed with 4% paraformaldehyde
solution for 15 min at 4 ◦C and then washed with PBS. The nuclei of cells were stained with DAPI
(300 nM; Invitrogen, Waltham, MA, USA) at 25 ◦C for 5 min and fluorescent images (358/461 nm) were
acquired in parallel with widefield (WF) images.
2.10. Statistical Analysis
All statistical analyses were performed using Sigma Plot software (Version 12, Systat Software Inc.,
San Jose, CA, USA). The data presented correspond to the mean ± standard deviation (n = 3). Data were
evaluated by two-way analysis of variance followed by Turkey’s multiple comparison tests. Statistical
significance was observed when compared cryopreserved and non-preserved samples at the same time
point and same samples at different experimental points at a level of *p < 0.05, **p < 0.01, ***p < 0.001.
3. Results
3.1. Bioprinted Osteoblast Constructs
Figure 1 shows that 3D-bioprinted osteoblast constructs were structurally stable after crosslinking
with CaCl2 solution. Both, MG-63 and Saos-2 constructs showed initial cell viability of 80%.
The automatic deposition allowed the fabrication of osteoblast constructs with identical shape directly
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in the 24-well cell culture plate (Figure 1b), reducing the risk of samples contamination. Moreover,
the constructs reproduced with fidelity the cartesian pattern after 3D-bioprinting (Figure 1b) and
retained the architecture after immersion in cell culture medium at 37 ◦C (Figure 1c).
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Figure 1. Representative images of 3D-bioprinted osteoblast constructs: (a) construct fully swelled,
(b) 24 constructs automatically bioprinted in the cell culture plate and (c) construct immersed in cell
culture medium at 37 ◦C after crosslinking with CaCl2.
3.2. Culture and Cryopreservation of Bioprinted st t cts
Figure 2 shows the cell metabolic activit f t - d Saos-2 constructs with and without
cryopreservation. In artic lar, the cryopreserved constructs were frozen at day 3 of culture and
after thawing were cultivated for a total of 7 days. The cell metabolic activity of the non-preserved
constructs increased more than 1.3 times between 3 and 7 days of culture, however, without showing
statistically significant differences due to the dispersion in the results. The cultures were not maintained
longer than 7 days because, similar to previous works, the constructs loosed their structural integrity
due to the progressive dissolution of uncrosslinked gelatine [29,30]. The two types of osteoblast
constructs were metabolically active after cryopreservation, but the metabolic activity was reduced
to the half of the non-preserved constructs (day 3). MG-63 constructs showed a quiescent phase
after cryopreservation, showing 1.3 times the cell metabolic activity of day 3 and only reaching 36%
of activity of the non-preserved constructs at day 7. In contrast, Saos-2 cryopreserved constructs
recovered faster their metabolic activity, showing no statistically significant differences in comparison
to non-preserved constructs at day 7 and 1.5 times higher activity than at day 3.
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Figure 2. Cell metabolic activity of 3D-bioprinted osteoblast constructs with or without cryopreservation
after 3 days of culture: (a) MG-63 constructs and (b) Saos-2 constructs. The results are expressed as
relative fold change compared to the cell metabolic activity obtained on day 3 without cryopreservation.
Asterisks indicate statistically significant differences at *p < 0.05, **p < 0.01, ***p < 0.001, n = 3.
The differences between MG-63 and Saos-2 constructs were also observed in terms of ALP
activity (Figure 3). Without cryopreservation, the ALP activity of MG-63 constructs did not change
over the culture time, while it increased 1.4 times in Saos-2 constructs. However, the increment
was not statistically significant. In general, the ALP activity of Saos-2 constructs was two times
higher than that of MG-63 constructs due to the more mature osteoblastic phenotype. No statistically
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significant differences in ALP activity were observed at day 3 within the same type of construct
due to cryopreservation (p = 0.177 for MG-63 and p = 0.577 for Saos-2). The cryopreserved MG-63
constructs showed a five-fold reduction in ALP activity after 7 days of culture, while the cryopreserved
Saos-2 constructs showed higher ALP activity, but not statistically significant (p = 0.315), than their
non-preserved counterparts, indicating in this case the recovery of the osteoblast function.
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indicate statistically significant differences at *p < 0.05, ***p 0.001, n = 3.
The r covery of the osteoblastic functio f t r reserved Saos-2 constructs is als observed
in the optical microscope images in Figure 4. -63 constructs appeared visually clearer (Figure 4a)
than Saos-2 constructs (Figure 4b) after 7 days of culture. The darker aspect of the cryopreserved
Saos-2 constructs was due to the deposition of calcium mineral salts, as confirmed by the positive
Alizarin red S staining (Figure 4c). The two types of constructs contain rounded cells distributed over
the whole structure (Figure 4a,b). The regions rich in calcium minerals stained with Alizarin red S
have globular morphology and are bigger than individual cells.
3.3. Culture of Hydrogel Encapsulated Saos-2 Cells in β-TCP Scaffolds
The β-TCP scaffolds with cartesian grid pattern were successfully fabricated by robocasting
(Figure 5a). The macropore size in the longitudinal direction (printing plane) was close to ~350 µm
instead than nominal 400 µm due to the shrinkage of the scaffolds during sintering. Furthermore,
Figure 5a shows that the strands of the scaffolds have a microstructure of smooth polyhedral grains
and 15% of micropores, around 1 µm in size. The porous network allowed the easy infiltration of the
cell-loaded hydrogel inside the scaffolds. Moreover, the use of β-TCP scaffolds removed the problem
of structural integrity loosening, allowing the culture and manipulation of the osteoblast constructs for
at least 21 days (Figure 5b). Despite the opacity of β-TCP scaffolds, the translucence of the hydrogel
allowed the imaging of the cells through the open macropores of the scaffold. The cells grew in
globular aggregates with size between 50 and 80 µm, homogeneously distributed inside the macropores
(Figure 5b), as corroborated by the fluorescent staining of the cell nuclei (Figure 5c). Furthermore,
the cell metabolic activity increased over time (Figure 5d), corroborating the cytocompatibility of the
hydrogel infiltrated in the scaffolds. It was not evident the cell migration towards the surface of the
scaffolds, but occasionally som cells were o served lining some areas of the surface of the strands
(Figure 5e).
3.4. Cryopreservation of H dr gel Encapsulated Saos-2 C lls Cultured in β-TCP Scaffolds
Figure 6 shows the cell metabolic activity and the ALP activity of osteoblast constructs consisting of
hydrogel encapsulated Saos-2 cells infiltrated in β-TCP scaffolds. Both, the cell metabolic activity and
the ALP activity, with and without cryopreservation, increased through the culture time, showing that
though the activities were reduced, the constructs were metabolically active and retained the osteoblastic
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phenotype after cryopreservation. The lowest activities were observed for the constructs frozen at day 3
of pre-culture, always showing values statistically below the non-preserved constructs. In other words,
they did not have enough time to fully recover. In contrast, when the constructs were cryopreserved
after 7 days of pre-culture, both, the cell metabolic activity and the ALP activity were between the values
obtained for non-preserved constructs and constructs cryopreserved at day 3. Moreover, at day 14 the two
activities did not show statistically significant differences with respect to the non-preserved constructs.
Therefore, the osteoblast constructs entirely recovered the activity and function. Lastly, no construct
presented signals of structural damage due to thermal shock during cryopreservation.
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4. Discussion
The effects of the cryopreservation on the biological behaviour of osteoblasts (MG-63 and Saos-2)
were studied either in 3D-bioprinted cell containing structures or in cells encapsulated in a hydrogel
inside of β-TCP scaffolds. In general, the results prove the feasibility of cryopreserving the osteoblast
constructs following a simple and low-cost methodology equivalent to that used for the cryopreservation
of cells [37] and human embryos [38]. The primary challenge for the sucesfull cryopreservation of
osteoblast constructs is to avoid the death of the cells due to cryoinjury produced by intracellular
ice formation and cell dehydration [39,40]. The growth of ice crystals is suppressed by reducing the
cooling rate during freezing. It is well accepted that cooling rates around 1 ◦C/min are effective for
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cryopreservation of cells [37]. However, such a slow cooling rate allows the dehydration of the cells
leading to their death due to osmotic shock. Thus, permeating or non-permeating cryoprotectant
additives are required to avoid cell dehydration. DMSO was used in this work as a cryoprotectant
additive because it is traditionally the common cryoprotectant used in cell biology laboratories [37,41].
DMSO also offers the advantage of permeating deep into tissues rapidly [37], thus, (as uncovered in
this work) allowing the protection of the cells in 3D, deep inside the hydrogels used for biofabrication.
The results of this work reveal important aspects that must be considered for the successful
cryopreservation of osteoblast constructs. For example, mature phenotype osteoblasts, such as mineral
forming Saos-2 cells, recovered their cell metabolic activity, ALP activity and the ability to deposit
nodules of mineralization after the cryopreservation faster than pre-osteoblasts or immature osteoblasts,
such as MG-63 cells. The reasons for these observations are still unknown and further studies are
required to understand the reasons for the loss of function of immature osteoblasts. Furthermore, and
in agreement with previous studies on the cryopreservation of hepatocytes and human embryonic stem
cells [22,42], the pre-cryopreservation culture period has important effects on the metabolic activity
and function maintain by osteoblasts, which recover normal values faster when cryopreserved after
longer-term of culture (7 days) than at shorter-term (3 days). The production of the bone extracellular
matrix probably protects the osteoblasts from cryoinjury. In fact, macromolecules such as proteins
in FBS or the extracellular matrix, act as cryoprotectant additive by reducing the freezing point of
DMSO, therefore minimizing the risk of intracellular ice formation, and also protect the cells from
dehydration [43,44]. Another benefit of longer culture before cryopreservation is the formation of more
cell–cell and cell–extracellular matrix adhesions that have been shown to reduce cryoinjury [20,42,45].
The use of β-TCP scaffolds further improves the osteoblast survival after cryopreservation, which
in turn results in similar levels of ALP activity in comparison with the non-preserved constructs.
Although the real factors responsible for this are unknown, it is hypothesized that the microstructure
of the scaffold protect the cells better from dehydration through a capillary force related mechanism.
Finally yet importantly, the stiff β-TCP scaffolds provide the load-bearing capacity to the osteoblast
construct, without compromising the viability of the cells. Despite not being measured in this study,
the compressive strength of β-TCP scaffolds range from 1 to 20 MPa [36,46], three orders of magnitude
above the stiffness of hydrogels; this is an important advantage for the structural integrity and
improved manipulation of the osteoblast constructs. Furthermore, the β-TCP scaffolds may provide
a microenvironment similar to that of the natural bone. Previous studies showed that the ionic
interactions of calcium phosphate ceramics with the physiological environment could promote the
differentiation of osteoblasts or mesenchymal stromal cells into the osteoblastic phenotype [47–49].
Although the cryopreservation of ready-to-use bone constructs is desirable, for the application in
practice there is still the need to study long-term cryopreservation at a lower temperature than −80 ◦C
and how the gene expression is up or down regulated due to cryopreservation. Another issue to be
studied is the difference in phenotype between osteosarcoma cell lines and primary osteoblasts [50].
In general, the lower proliferation rate and contact inhibition growth of primary osteoblasts could
make more challenging their successful cryopreservation. Preliminary results show a 50% survival
rate of rabbit-derived primary osteoblasts in comparison with 80% of Saos-2 cells [26].
While for a 3D in vitro model it is enough to have a reproducible cryopreservation method
that does not damage the cells, neither compromise their activity and function after thawing, more
demanding requirements arise for the clinical applications [16,40]. One concern is the use of FBS either
as a bioink or as cryoprotectant supplement since it introduces the risk of immunological rejection and
the transmission of diseases. The alternative is the use of xeno-free cryoprotectant supplements [51,52].
Moreover, for the implementation of autologous cell therapies, there is still the need for primary
cell extraction and expansion, making more challenging the treatment of bone injuries that require
immediate attention.
When tackling all these issues will be possible to offer the bone constructs off-the-shelf all over
the world. The distribution of on-demand manufactured constructs ought to be less expensive and
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less time consuming than their in situ biofabrication, providing this technology to a greater number
of researchers and clinicians not engaged in biofabrication but with other relevant scientific interests.
It is predicted that this will spread the safe and reliable use of biofabricated bone constructs, either as
in vitro bone tissue models or as bone grafts in regenerative medicine.
An alternative route to the described methodology is the cryopreservation of the osteoblast
constructs by vitrification, a non-equilibrium freezing technique that results in a glass formation instead
of growth of ice crystals through the combination of high concentration of cryoprotectant additive and
ultrarapid freezing [17,18].
5. Conclusions
This work shows that the short-term cryogenic preservation of osteoblast constructs is feasible in
DMSO at −80 ◦C. The results uncover that the cell metabolic activity and function of the osteoblast
constructs after thawing strongly depend on the maturity of the osteoblasts, the pre-cryopreservation
culture period and the use of β-TCP scaffolds. In general, the faster recovery was achieved when
mature osteoblast constructs were cryopreserved after long periods of pre-culture, preferably with
the use of β-TCP scaffolds. The β-TCP scaffolds also provided structural integrity to the constructs,
resulting in better handling and shape retention for a longer time. Since cell recovery depends on the
osteoblast maturity, there is still the need to assess the effects of cryopreservation on primary osteoblast
constructs, promoting the use of xeno-free cryoprotectant additives.
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